Sera Prognostics (SERA) Cost of Revenue (2020 - 2026)
Sera Prognostics posted quarterly Cost of Revenue of $42000.0 for Q1 2026, down 97.14% year-on-year from $1.5 million in Q1 2025, and up 100.89% on a QoQ basis from -$4.7 million in Q4 2025.
Sera Prognostics (SERA) has 7 years of Cost of Revenue data on file, last reported at $42000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue fell 97.14% year-over-year to $42000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.3 million (down 125.61% YoY), and the FY2025 full-year result was $164000.0, down 97.16% from the prior year.
- Cost of Revenue for Q1 2026 stood at $42000.0, up from -$4.7 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $4.5 million in Q1 2022 and bottomed at -$4.7 million in Q4 2025.
- The 5-year median for Cost of Revenue is $1.6 million (2025), against an average of $1.6 million.
- Peak annual rise in Cost of Revenue reached 9005.0% in 2025, while the deepest fall reached 308.44% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $3.1 million in 2022, then tumbled by 57.32% to $1.3 million in 2023, then jumped by 73.62% to $2.3 million in 2024, then plunged by 308.44% to -$4.7 million in 2025, then soared by 100.89% to $42000.0 in 2026.
- The last three Cost of Revenue figures came in at $42000.0 (Q1 2026), -$4.7 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Sera Prognostics | 30.02 Mn | 30.02 Mn | -28,000.00 | 42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,000.00 |
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | -4.72 Mn |
| Dec 31, 2025 | -4.72 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 2.87 Mn |
| Jun 30, 2023 | 2.87 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Dec 31, 2022 | 3.06 Mn |
| Sep 30, 2022 | 2.97 Mn |
| Sep 30, 2022 | 2.97 Mn |
| Jun 30, 2022 | 4.22 Mn |
| Jun 30, 2022 | 4.22 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 4.55 Mn |
| Dec 31, 2021 | 4.55 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 1.74 Mn |
| Mar 31, 2021 | 1.35 Mn |
| Mar 31, 2021 | 1.35 Mn |
| Dec 31, 2020 | 1.01 Mn |
| Dec 31, 2020 | 1.01 Mn |
| Sep 30, 2020 | 1.05 Mn |
| Sep 30, 2020 | 1.05 Mn |
| Jun 30, 2020 | 712,000.00 |
| Jun 30, 2020 | 712,000.00 |